Skip to content
Listen
Newsletters
Shows
How We Survive
Marketplace
Marketplace Morning Report
Marketplace Tech
Make Me Smart
This is Uncomfortable
Million Bazillion
The Uncertain Hour
Marketplace Minute®
Corner Office from Marketplace
Marketplace Logo
Marketplace Logo
Newsletters
Shows
How We Survive
Marketplace
Marketplace Morning Report
Marketplace Tech
Make Me Smart
This is Uncomfortable
Million Bazillion
The Uncertain Hour
Marketplace Minute®
Corner Office from Marketplace
Facebook
Twitter
Instagram
Youtube
Donate
Search
Menu
Menu
Search
Explore
Latest Stories
Our Shows
Collections
Smart Speaker Skills
Music
Find Your Local Station
Corrections
Company
FAQs
Submissions
Staff
Careers
Support Us
Individuals
Corporate Sponsorship
Foundations
Shop
Follow Us
Facebook
Twitter
Instagram
Youtube
Newsletters
Talk to Us
Russia-Ukraine War
Economic Pulse
Million Bazillion Academy
I've Always Wondered ...
Make Me Smart Daily
Your browser does not support the audio format.
Loading...
More From This Show
0:00
/
0:00
0% played
Stories Tagged as
Biogen
Medicare proposes limiting coverage of controversial Alzheimer's drug
by
Lily Jamali
Jan 13, 2022
Government insurer won't cover Aduhelm's $28,000-a-year price tag except for clinical trials.
DOMINICK REUTER/AFP via Getty Images
Listen
LISTEN
Download
Download
READ MORE
READ MORE
HTML EMBED:
<iframe id="mp_403109" title="Marketplace Embed" src="https://www.marketplace.org/2022/01/13/medicare-proposes-limiting-coverage-of-controversial-alzheimers-drug//popout" frameborder="0" width="100%" height="240px"></iframe>
COPY
EMBED
EMBED
Share Now on:
Facebook
Twitter
LinkedIn
Email
https://www.marketplace.org/2022/01/13/medicare-proposes-limiting-coverage-of-controversial-alzheimers-drug/
COPY THE LINK
SHARE
SHARE
Subscribe Using:
Apple
Spotify
Amazon Music
Google
Stitcher
RSS
SUBSCRIBE
SUBSCRIBE
Who will end up paying the price for Biogen's new Alzheimer's drug?
by
Kimberly Adams
Jun 18, 2021
The cost of the newly approved treatment will be about $56,000 a year, much of it paid for by Medicare.
Dominick Reuter/AFP via Getty Images
Listen
LISTEN
Download
Download
READ MORE
READ MORE
HTML EMBED:
<iframe id="mp_351870" title="Marketplace Embed" src="https://www.marketplace.org/2021/06/18/who-will-end-up-paying-the-price-for-biogens-new-alzheimers-drug//popout" frameborder="0" width="100%" height="240px"></iframe>
COPY
EMBED
EMBED
Share Now on:
Facebook
Twitter
LinkedIn
Email
https://www.marketplace.org/2021/06/18/who-will-end-up-paying-the-price-for-biogens-new-alzheimers-drug/
COPY THE LINK
SHARE
SHARE
Subscribe Using:
Apple
Spotify
Amazon Music
Google
Stitcher
RSS
SUBSCRIBE
SUBSCRIBE
